Autoimmunity_YHLO

YHLO

YHLO

Language

Reproductive Health

Home page

2024/06/05

Using two-step cluster analysis to classify inpatients with primary biliary cholangitis based on autoantibodies A real-world retrospective study of 537 patients in C.pdf

2024/06/05

Validation of three prediction models for thrombosis recurrence in antiphospholipid syndrome patients based on a prospective cohort

2024/06/05

Diagnostic and prognostic value of quantitativedetection of antimitochondrial antibodies

2024/06/05

Lack of comparability of immunoassays for rheumatoid factor isotypes

2024/06/05

Serum Calprotectin as a Potential Predictor of Microvascular Manifestations in Patients with Antiphospholipid Syndrome

2024/06/05

A predictive model for disease severity among COVID-19 elderly patients based on IgG subtypes and machine learning

2024/06/05

Exploring clinical indicator variations in stroke patients with multiple risk factors focus on hypertension and inflammatory reactions

2024/06/05

Recognition of rare antinuclear antibody patterns based on a novel attention-based enhancement framework

2024/06/05

Human Leucocyte Antigen Alleles and Haplotypes and Their Associations With Antinuclear Antibodies Features in Chinese Patients With Primary Biliary Cirrhosis

2024/05/29

Publications 2024.05

< 1 2 3 >

YHLO

Home
Products
- CLIA
  - Analyzers
  - Reagents
- Chemistry
- TLA
- LIA
- ESR
Pubilcations
- Autoimmunity
- Reproductive Health
- Diabetes
- Liver Disease
- Infection
- COVID-19
- ESR
- Others
News
- YHLO News
- Marketing Activities
About YHLO
Contact us
- Career
- Service

Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China

Tel: +86 755 26601910

Email: marketing@szyhlo.com

youtube

instagram

wechat

wechat

Copyright© 2024 Shenzhen YHLO Biotech Co., Ltd.

Powered by 300.cn | SEO | Business License

8

Email

marketing@szyhlo.com

9

Tel

+86 755 26601910